T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.45B |
| 2 |
Pinterest
PINS
|
+$1.89B |
| 3 |
T-Mobile US
TMUS
|
+$1.89B |
| 4 |
Zoom
ZM
|
+$1.77B |
| 5 |
UiPath
PATH
|
+$1.71B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$3.66B |
| 2 |
Caterpillar
CAT
|
+$1.32B |
| 3 |
Netflix
NFLX
|
+$1.18B |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.15B |
| 5 |
Micron Technology
MU
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.62% |
| 2 | Healthcare | 16.07% |
| 3 | Consumer Discretionary | 15.29% |
| 4 | Communication Services | 13.46% |
| 5 | Financials | 12.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Fate Therapeutics
FATE
$317M
| $270M | 0.03% |
3,109,832
-39,274
| -1% | -$3.16M |
|
477
PROG Holdings
PRG
$1.64B
| $270M | 0.03% |
5,607,609
-125,161
| -2% | -$6.23M |
|
478
Xcel Energy
XEL
$49.1B
| $269M | 0.02% |
4,077,923
-692,046
| -15% | -$48.2M |
|
479
Boston Scientific
BSX
$74.5B
| $266M | 0.02% |
6,225,607
-289,028
| -4% | -$12.2M |
|
480
DuPont de Nemours
DD
$19.5B
| $265M | 0.02% |
2,730,778
-4,436,213
| -62% | -$446M |
|
481
Colgate-Palmolive
CL
$73.6B
| $265M | 0.02% |
3,258,832
-1,037,469
| -24% | -$84.8M |
|
482
SS&C Technologies
SSNC
$18.8B
| $265M | 0.02% |
3,676,542
-71,126
| -2% | -$5.2M |
|
483
Post Holdings
POST
$3.65B
| $264M | 0.02% |
3,725,243
-45,005
| -1% | -$3.32M |
|
484
Gen Digital
GEN
$17.1B
| $264M | 0.02% |
9,696,139
-8,778,353
| -48% | -$219M |
|
485
SPX Corp
SPXC
$10.9B
| $260M | 0.02% |
4,262,464
+327,361
| +8% | +$19.9M |
|
486
Kraft Heinz
KHC
$29.1B
| $259M | 0.02% |
6,356,331
-366,585
| -5% | -$15.4M |
|
487
ESCO Technologies
ESE
$7.78B
| $255M | 0.02% |
2,723,277
+39,415
| +1% | +$3.98M |
|
488
Graco
GGG
$13.4B
| $252M | 0.02% |
3,330,673
+110,443
| +3% | +$8.29M |
|
489
SouthState Bank Corp
SSB
$10.7B
| $252M | 0.02% |
3,079,269
-517,703
| -14% | -$44M |
|
490
Idacorp
IDA
$8.21B
| $250M | 0.02% |
2,566,513
+77,096
| +3% | +$7.73M |
|
491
PennyMac Financial
PFSI
$4B
| $250M | 0.02% |
4,054,169
-841,232
| -17% | -$51.1M |
|
492
Campbell Soup
CPB
$6.74B
| $249M | 0.02% |
5,463,830
+1,596,571
| +41% | +$76.9M |
|
493
Acadia Pharmaceuticals
ACAD
$5.07B
| $249M | 0.02% |
10,198,831
+1,844,820
| +22% | +$41.6M |
|
|
NEE.PRP
494
DELISTED
NextEra Energy, Inc. 5.279% Corporate Units
NEE.PRP
| $248M | 0.02% |
5,067,757
-9,877
| -0.2% | -$488K |
|
495
Ollie's Bargain Outlet
OLLI
$4.73B
| $247M | 0.02% |
2,941,427
-251,000
| -8% | -$21.8M |
|
496
Doximity
DOCS
$4.45B
| $247M | 0.02% |
+4,244,609
| New | +$238M |
|
|
PPBI
497
DELISTED
Pacific Premier Bancorp
PPBI
| $246M | 0.02% |
5,811,302
-448,264
| -7% | -$19.9M |
|
498
Workiva
WK
$3.7B
| $246M | 0.02% |
2,206,801
+292,834
| +15% | +$28.4M |
|
499
Reliance Steel & Aluminium
RS
$21.8B
| $244M | 0.02% |
1,618,043
+421,896
| +35% | +$68.5M |
|
500
Selective Insurance
SIGI
$5.59B
| $244M | 0.02% |
3,007,159
+284,402
| +10% | +$21.7M |
|
Similar funds
T. Rowe Price Associates's Q2 2021 Portfolio in Review
As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
- T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
- T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
- T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
- T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
- T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.
Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.